Crescent Capital BDC

CCAP

Market cap $407M

The risk-return tradeoff is the financial principle according to which potentially higher returns require accepting higher risk. Risk is the potential for monetary loss or default stemming from market volatility, excessive debt, or unexpected economic downturns. When it comes to volatility, the main culprit is often leverage—the use of borrowed money to fund investments with the goal of multiplying returns.

Crescent Capital BDC, Inc. faces ongoing headwinds, with a 19% dividend cut following rising non-accruals and declining investment income. Despite a steep 39% discount to NAV and a 12%+ yield, I remain cautious given persistent inflation and the potential for further downside. CCAP's Q1 saw net investment income drop to $0.38/share and non-accruals spike to 5.7% at cost, pressuring NAV and dividend sustainability.

Crescent Capital BDC, Inc. trades at a 39% NAV discount after a 19% dividend cut was announced due to falling NII. CCAP's non-accrual ratio doubled year-over-year to 3.6%, based on fair value, pressuring net investment income and dividend coverage. The portfolio is 92% first liens, and the forward dividend yield is 12%, with Q1'26 coverage at 1.0x.

Crescent Capital BDC, Inc. continues to underperform the index. Part of it is justified; part of it isn't. As of today, CCAP trades 40% below NAV and offers a yield of almost 13% that is underpinned by strong earnings coverage.

ACRE, CWST and CCAP have been added to the Zacks Rank #5 (Strong Sell) List on June 16, 2026.

CCAP, DAVA and RH have been added to the Zacks Rank #5 (Strong Sell) List on June 12, 2026.

LOS ANGELES & NEW YORK & BOSTON & CHICAGO--(BUSINESS WIRE)--Crescent Capital Group LP (“Crescent”), one of the leading alternative credit investment firms, announced today the successful final close of its fourth U.S. direct lending fund, Crescent Direct Lending Fund IV (“CDL Fund IV”), raising $10.8 billion in investable capital, including targeted leverage and separately managed accounts investing alongside the fund. CDL Fund IV represents the latest vintage in Crescent's lower middle market.

Dividend investing provides a consistent income stream, beneficial for those seeking passive income, while growth stocks may require selling shares to realize gains. Seeking dividend income does not rule out focusing on the growth of the portfolio's nominal value, thanks to many funds that see their NAV grow over time. These securities offer a dual advantage: immediate returns through regular, periodic distributions, and capital appreciation through long-term NAV increase.

There is a principle I have followed for 30 years in this business. When the smartest credit team on the planet starts aggressively buying a beaten-down asset class they understand better than anyone alive, you do not sit on your hands and debate whether the timing is perfect.

Crescent Capital BDC trades near a 52-week low, offering a 13% yield and a deep 0.61x price-to-book discount. CCAP's first-lien-heavy, diversified portfolio and recent management fee reductions support strong NII-to-dividend coverage at 113.5%. Nonaccruals rose to 3.6% of portfolio value, mainly in healthcare, but management actively manages these with meaningful control.